MYC and cancer: A growing number of cancer-related proteins are O-GlcNAc modified, for instance, MYC (Chou et al., 1995a,b) and the core components of Hippo signaling, including YAP (Peng et al., 2017; Zhang et al., 2017) and LATS2 (Kim et al., 2020).